Clinical Trials Logo

Opioid-Related Disorders clinical trials

View clinical trials related to Opioid-Related Disorders.

Filter by:

NCT ID: NCT00000252 Completed - Clinical trials for Substance-Related Disorders

Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4

Start date: June 1994
Phase: Phase 2
Study type: Interventional

The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To examine the lack of acute tolerance development to the subjective, cognitive, and psychomotor effects of nitrous oxide in healthy volunteers.

NCT ID: NCT00000251 Completed - Clinical trials for Substance-Related Disorders

Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3

Start date: April 1994
Phase: Phase 2
Study type: Interventional

The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To evaluate the acute and residual effects of subanesthetic concentrations of isoflurane/nitrous oxide combinations in healthy volunteers.

NCT ID: NCT00000250 Completed - Clinical trials for Substance-Related Disorders

Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2

Start date: December 1993
Phase: Phase 2
Study type: Interventional

The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To evaluate: cold water immersion modulates the reinforcing effects of nitrous oxide in healthy volunteers.

NCT ID: NCT00000249 Completed - Clinical trials for Substance-Related Disorders

Effects of Subanesthetic Concentrations of Nitrous Oxide - 1

Start date: September 1993
Phase: Phase 2
Study type: Interventional

The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To examine effects of subanesthetic concentrations of nitrous oxide on cold-pressor pain in humans.

NCT ID: NCT00000244 Completed - Clinical trials for Opioid-Related Disorders

Effects of Dynorphin 1-13 on Heroin Addiction - 1

Start date: August 1994
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effects of IV dynorphin in humans during acute heroin abstinence, in order to determine that dynorphin suppresses acute opiate withdrawal, reduces opiate craving, and is safe at doses required to produce the above effects.

NCT ID: NCT00000240 Completed - Clinical trials for Opioid-Related Disorders

Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22

Start date: April 1999
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test combined buprenorphine and behavioral treatment with and without contingent reinforcement on opioid and cocaine abstinence.

NCT ID: NCT00000239 Completed - Clinical trials for Opioid-Related Disorders

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to examine if chronic buprenorphine administration will generate supersensitivity to opiates.

NCT ID: NCT00000238 Completed - Clinical trials for Opioid-Related Disorders

Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20

Start date: August 1997
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the degree in which opioid-dependent outpatients discount the value of an additional maintenance dose of buprenorphine under differing states of opioid deprivation.

NCT ID: NCT00000237 Completed - Clinical trials for Opioid-Related Disorders

Buprenorphine Detoxification - BBDVI - 19

Start date: May 1997
Phase: Phase 2
Study type: Interventional

The purpose of this study is to examine the long-term efficacy of alternate-day dosing schedules in promoting treatment compliance in the absence of confounding behavioral contingencies.

NCT ID: NCT00000236 Completed - Clinical trials for Opioid-Related Disorders

Buprenorphine Pharmacology Related to Addiction Treatment - 18

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to examine the interactions between buprenorphine and naltrexone, and to assess how they may directly impact the clinical issues involving: transferring patients from buprenorphine to naltrexone, developing a non-abusable form of buprenorphine, and enhancing patient acceptability of naltrexone.